title: Identifying Inhibitors of the Hsp90-Aha1 Protein Complex, a Potential Target to Drug Cystic Fibrosis, by Alpha Technology.
abstract: Deletion of a single phenylalanine residue at position 508 of the protein CFTR (cystic fibrosis transmembrane conductance regulator), a chloride channel in lung epithelium, is the most common cause for cystic fibrosis. As a consequence, folding of the CFTRΔF508 protein and delivery to the cell surface are compromised, resulting in degradation of the polypeptide. Accordingly, decreased surface presence of CFTRΔF508 causes impaired chloride ion conductivity and is associated with mucus accumulation, a hallmark of cystic fibrosis. Molecular chaperones such as Hsp90 and its co-chaperone partner Aha1 are thought to play a key role in targeting folding-deficient CFTRΔF508 for degradation. Thus, pharmacologic manipulation to inhibit Hsp90-Aha1 chaperone complex formation appears beneficial to inhibit proteolysis of CFTRΔF508 and rescue its residual chloride channel activity. Therefore, we have screened a collection of 14,400 druglike chemical compounds for inhibitors of the Hsp90-Aha1 complex by amplified luminescence proximity homogeneous assay (Alpha). We identified two druglike molecules that showed promising results when we tested their ability to restore chloride channel activity in culture cells expressing the mutant CFTRΔF508 protein. The two molecules were most effective in combination with the corrector VX-809 and may therefore serve as a lead compound that can be further developed into a drug to treat cystic fibrosis patients.
authors.affiliation: 1 Department of Cardiovascular Physiology, Ruhr-University Bochum, Bochum, Germany.
authors.forename: Verena
authors.initials: V
authors.lastname: Ihrig
authors.affiliation: 1 Department of Cardiovascular Physiology, Ruhr-University Bochum, Bochum, Germany.
authors.forename: Wolfgang M J
authors.initials: WMJ
authors.lastname: Obermann
mesh_terms: D001681:Biological Assay / Q000379:methods*; D002460:Cell Line; D018118:Chloride Channels / Q000378:metabolism; D003550:Cystic Fibrosis / Q000378:metabolism*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000378:metabolism; D018841:HSP90 Heat-Shock Proteins / Q000378:metabolism*; D006801:Humans; D018832:Molecular Chaperones / Q000378:metabolism; D050505:Mutant Proteins / Q000378:metabolism; D017510:Protein Folding; D021381:Protein Transport / Q000502:physiology; D059748:Proteolysis
chemical_list: D018118:Chloride Channels; D018841:HSP90 Heat-Shock Proteins; D018832:Molecular Chaperones; D050505:Mutant Proteins; D019005:Cystic Fibrosis Transmembrane Conductance Regulator
keywords: Aha1 (activator of Hsp90 ATPase activity); Alpha (amplified luminescence proximity homogeneous assay); CFTR (cystic fibrosis transmembrane conductance regulator); cystic fibrosis; heat shock protein (Hsp90)